Meinong Bio released its 2026 interim report. Total operating revenue was 328 million yuan, and net profit attributable to the parent company was 18.061 million yuan, down 23.23% from the same period last year. Net cash flow from operating activities was negative 6.9286 million yuan, down 117.21% year-on-year. The company's latest asset-liability ratio was 9.98%, gross margin was 29.53%, ROE was 2.48%, and diluted earnings per share was 0.10 yuan. The number of shareholders was 7,943, and the top ten shareholders held 69.88% of the shares.
Shanghai Menon Animal Nutrition Technology Co. Ltd.Net profit down 23.23% year-on-year in interim report